GlaxoSmithKline (GSK) has announced plans to set up a new online system that will enable researchers to access anonymous patient-level data from its clinical trials.
A newly report published by a center-right think tank makes the claim that incoming value-based pricing regulations could lead to difficulties in patients accessing treatment.
A US comprehensive Cancer Centre has discovered that a biological data facility can accelerate recruitment, lower costs, minimise trial size and expedite the testing of medicines during drug development.
The growth of US health care costs has slowed substantially, giving hope to Americans that they may save as much as $770 billion on Medicare spending over the next decade, Harvard economists say. But how long will this cost respite actually last?
India’s Drug Controller General is to increase monitoring of clinical trials following health activists’ pushing for tougher regulations in the Supreme Court, as concerns continue to arise about the safety and integrity of trials across the country.
A three-dimensional ‘heart patch’ is the world’s first synthetically grown human heart muscle, an accurate estimate of traditional human heart tissue that can help test multiple new therapies for affected patients.
Last week, the state of Florida passed legislation allowing for the substitution of biologics with biosimilars alternatives, joining a growing list of states in America to do so.
The European Medicines Agency (EMA) has just released its final advice resulting from the clinical trial advisory groups set up last year. The next step will be the drafting of a policy on proactive access to clinical-trial data ready for consultation mid-2013.
Mark A. Yarborough, PhD, of the Bioethics Program, University of California Davis, has called for patients to see participating in clinical trials as a "civic" duty, proposing “coordinated campaigns to cultivate civic attitudes” about trials.
Two years after receiving Medicaid coverage, the mental health and financial well-being of the beneficiaries fared substantially better than a random uninsured group of the same low income. But clear physical health benefits among scheme recipients have yet to be seen.
EU citizens are unable to afford life-saving medication due to ongoing cuts and austerity measures...
Pharma firms are looking to collaborate with the right delivery device partners as a number of...
Jeff Elton examines the collaborative, risk-sharing relationships necessary between Big Pharma and...
